GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers

Journal of Nutrition, Health and Aging

Volumn 13, Issue 3, 2009, Pages 214-219

  Ramírez Lorca, Reposo ^a,g   Boada, M ^b,c   Saez, M E ^a   Hernandez, I ^b   Mauleon, A ^b   Rosende Roca, M ^b   Martinez Lage, P ^b   Gutierrez, M ^a   Real, L M ^a   Lopez Arrieta, J ^d   Gayan, J ^a   Antunez, C ^e,f   Gonzalez Perez, A ^a   Tarraga, L ^b   Ruiz, A ^a  

^a Neocodex   (Spain)

^b Catalan Institute of Applied Neurosciences   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^f Alzheimur Foundation   (Spain)

^g NONE   (Spain)

Author keywords

Alzheimer's disease; APOE; GAB2; Genetic association studies; SNP

Indexed keywords

APOLIPOPROTEIN E4; BINDING PROTEIN; GRB ASSOCIATED BINDING PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC MODEL; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PLEIOTROPY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SPAIN;

EID: 63249096555     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12603-009-0061-6     Document Type: Article

References (28)

1. Evans DA, Beckett LA, Field TS, et al. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. Jama. 1997;277:822-824.
2. Parihar MS, Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci. 2004; 11:456-467.
3. Crutcher KA. Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer's disease. J Mol Neurosci. 2004;23:181-188.
4. Bertram L, McQueen MB, Mullin K, et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature genetics. 2007;39:17-23.
5. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE°4 a 'thrifty' allele? Annals of human genetics. 1999;63:301-310.
6. Reiman EM, Webster JA, Myers AJ, et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron. 2007;54:713-720.
7. Crawford F, Fallin D, Sun Z, et al. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations. Neuroscience letters. 1998;249:115-118.
8. Hiltunen M, Mannermaa A, Helisalmi S, et al. Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients. Neuroscience letters. 1998;250:69-71.
9. Lehmann DJ, Johnston C, Smith AD. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Human molecular genetics, 1997;6:1933-1936.
10. McCusker SM, Curran MD, Dynan KB, et al. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet. 2001;357:436-439.
11. Reynolds WF, Hiltunen M, Pirskanen M, et al, MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males. Neurology. 2000;55:1284-1290.
12. Wiebusch H, Poirier J, Sevigny P, et al. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease. Human genetics. 1999;104:158-163.
13. Brandi ML, Becherini L, Gennari L, et al. Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochemical and biophysical research communications. 1999;265:335-338.
14. Mattila KM, Axelman K, Rinne JO, et al, Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neuroscience letters. 2000;282:45-48.
15. Porrello E, Monti MC, Sinforiani E, et al. Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. Eur J Neurol. 2006;13:639-644.
16. Lambert JC, Coyle N, Lendon C. The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease. Journal of medical genetics. 2004;41:104-112.
17. Wang JM, Irwin RW, Brinton RD. Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103:16983-16988.
18. Coon KD, Myers AJ, Craig DW, et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. The Journal of clinical psychiatry. 2007;68:613-618.
19. Grupe A, Abraham R, Li Y, et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Human molecular genetics, 2007; 16:865-873.
20. Li H, Wetten S, Li L, et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Archives of neurology. 2008;65:45-53.
21. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
22. Ramirez-Lorca R, Grilo A, Martinez-Larrad MT, et al. Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants. Hypertension. 2007;50:884-890.
23. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. American journal of human genetics. 2007;81:559-575.
24. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiolog. 1992;3:452-456.
25. Yang Q, Khoury MJ, Sun F, et al. Case-only design to measure gene-gene interaction. Epidemiology. 1999; 10:167-170.
26. Lopez OL, Lopez-Pousa S, Kamboh MI, et al. Apolipoprotein E polymorphism in Alzheimer's disease: a comparative study of two research populations from Spain and the United States. European neurology. 1998;39:229-233.
27. Chapuis J, Hannequin D, Pasquier F, et al. Association study of the GAB2 gene with the risk of developing Alzheimer's disease. Neurobiology of disease. 2008;30:103-106.
28. Benuet AM, Di Angelantonio E, Ye Z, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. Jama. 2007;298:1300-1311.